US court rules in favour of Pfizer in Rapamune patent infringement case ... pharmabiz.com Pfizer Inc. announced that the United States District Court for the District of Delaware ruled that Pfizer's patent covering a method for using sirolimus, the active ingredient in Rapamune, for the inhibition of organ transplant rejection is valid and ... |
